"
Team:Bielefeld-Germany/Biosafety/Safety-Form
From 2013.igem.org
(Difference between revisions)
| Line 18: | Line 18: | ||
<br> | <br> | ||
[[File:IGEM Bielefeld 2013 Biosafety Safety form tab organisms.png|600px|thumb|center|Table of the chassis organisms we use for our project.]] | [[File:IGEM Bielefeld 2013 Biosafety Safety form tab organisms.png|600px|thumb|center|Table of the chassis organisms we use for our project.]] | ||
| - | + | <br> | |
<br> | <br> | ||
*2. Highest Risk Group Listed: | *2. Highest Risk Group Listed: | ||
**The highest risk group is one. | **The highest risk group is one. | ||
<br> | <br> | ||
| - | + | <br> | |
*3. List and describe all new or modified coding regions you will be using in your project. | *3. List and describe all new or modified coding regions you will be using in your project. | ||
<br> | <br> | ||
[[File:IGEM Bielefeld 2013 Biosafety tab codingregions zusammen.png|600px|thumb|center|Table of the coding regions we use in our project.]] | [[File:IGEM Bielefeld 2013 Biosafety tab codingregions zusammen.png|600px|thumb|center|Table of the coding regions we use in our project.]] | ||
<br> | <br> | ||
| - | + | <br> | |
*4. Do the biological materials used in your lab work pose any of the following risks? Please describe. | *4. Do the biological materials used in your lab work pose any of the following risks? Please describe. | ||
**a. Risks to the safety and health of team members or others working in the lab? | **a. Risks to the safety and health of team members or others working in the lab? | ||
| Line 39: | Line 39: | ||
***No. All our strains are based on E. coli K12. All the genes that are introduced are not suited for malicious misuse. | ***No. All our strains are based on E. coli K12. All the genes that are introduced are not suited for malicious misuse. | ||
<br> | <br> | ||
| - | + | <br> | |
*5. If your project moved from a small-scale lab study to become widely used as commercial/industrial product, what new risks might arise? Also, what risks might arise if the knowledge you generate or the methods you develop became widely available? <br> | *5. If your project moved from a small-scale lab study to become widely used as commercial/industrial product, what new risks might arise? Also, what risks might arise if the knowledge you generate or the methods you develop became widely available? <br> | ||
** If our system become widely used as a commercial/industrial product there doesn't arise new risks. It is only for producing electricity so this scenario has just positive consequences. | ** If our system become widely used as a commercial/industrial product there doesn't arise new risks. It is only for producing electricity so this scenario has just positive consequences. | ||
<br> | <br> | ||
| - | + | <br> | |
*6. Does your project include any design features to address safety risks?<br> | *6. Does your project include any design features to address safety risks?<br> | ||
**Yes it includes a kill switch and an especially safe auxotrophic chassis. | **Yes it includes a kill switch and an especially safe auxotrophic chassis. | ||
| - | + | <br> | |
| + | <br> | ||
*7. What safety training have you received (or plan to receive in the future)? Provide a brief description, and a link to your institution’s safety training requirements, if available. | *7. What safety training have you received (or plan to receive in the future)? Provide a brief description, and a link to your institution’s safety training requirements, if available. | ||
**All the members of our team received instructions by Mr. Dr. Jörn Kalinowski according to German lab safety regulations including working with biological genetically engineered materials.<br> | **All the members of our team received instructions by Mr. Dr. Jörn Kalinowski according to German lab safety regulations including working with biological genetically engineered materials.<br> | ||
| - | + | <br> | |
| + | <br> | ||
*8. Under what biosafety provisions will / do you work? | *8. Under what biosafety provisions will / do you work? | ||
**a. Please provide a link to your institution biosafety guidelines. | **a. Please provide a link to your institution biosafety guidelines. | ||
*** Our university has an own health, work and environment protection management system, certified with the British standard [http://uni-bielefeld.agu-hochschulen.de/index.php?id=714 „Occupational Health and Safety Assessment Series“ (BS OHSAS 18001)]: | *** Our university has an own health, work and environment protection management system, certified with the British standard [http://uni-bielefeld.agu-hochschulen.de/index.php?id=714 „Occupational Health and Safety Assessment Series“ (BS OHSAS 18001)]: | ||
Revision as of 08:31, 1 October 2013
Safety Form
Basic Safety Questions for iGEM 2013
- 1.Please describe the chassis organism(s) you will be using for this project. If you will be using more than one chassis organism, provide information on each of them:
- 2. Highest Risk Group Listed:
- The highest risk group is one.
- 3. List and describe all new or modified coding regions you will be using in your project.
- 4. Do the biological materials used in your lab work pose any of the following risks? Please describe.
- a. Risks to the safety and health of team members or others working in the lab?
- see 1)
- see 1)
- b. Risks to the safety and health of the general public, if released by design or by accident?
- No. All our strains are based on E. coli K12.
- No. All our strains are based on E. coli K12.
- c. Risks to the environment, if released by design or by accident?
- No. All our strains are based on E. coli K12.
- No. All our strains are based on E. coli K12.
- d. Risks to security through malicious misuse by individuals, groups, or countries?
- No. All our strains are based on E. coli K12. All the genes that are introduced are not suited for malicious misuse.
- a. Risks to the safety and health of team members or others working in the lab?
- 5. If your project moved from a small-scale lab study to become widely used as commercial/industrial product, what new risks might arise? Also, what risks might arise if the knowledge you generate or the methods you develop became widely available?
- If our system become widely used as a commercial/industrial product there doesn't arise new risks. It is only for producing electricity so this scenario has just positive consequences.
- 6. Does your project include any design features to address safety risks?
- Yes it includes a kill switch and an especially safe auxotrophic chassis.
- 7. What safety training have you received (or plan to receive in the future)? Provide a brief description, and a link to your institution’s safety training requirements, if available.
- All the members of our team received instructions by Mr. Dr. Jörn Kalinowski according to German lab safety regulations including working with biological genetically engineered materials.
- All the members of our team received instructions by Mr. Dr. Jörn Kalinowski according to German lab safety regulations including working with biological genetically engineered materials.
- 8. Under what biosafety provisions will / do you work?
- a. Please provide a link to your institution biosafety guidelines.
- Our university has an own health, work and environment protection management system, certified with the British standard [http://uni-bielefeld.agu-hochschulen.de/index.php?id=714 „Occupational Health and Safety Assessment Series“ (BS OHSAS 18001)]:
- a. Please provide a link to your institution biosafety guidelines.
